Tamim M. Niazi
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Multimodal Imaging of Response to Salvage Prostate Ablation.
Journal: Radiology. Imaging cancer
Published: September 04, 2026
Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: August 30, 2026
Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir.
Journal: Future oncology (London, England)
Published: June 19, 2026
Genetic testing practices among specialist physicians who treat prostate cancer: Updated survey of Canadian practitioners.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: April 06, 2026
Genetic testing practices among specialist physicians who treat prostate cancer Updated survey of Canadian practitioners.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: April 06, 2026
Pelvic nodes ultra-hypo fractionated versus conventionally fractionated IMRT with HDR brachytherapy in prostate cancer: interim analysis of a collaborative multi-institutional non-inferiority phase 3 trial (PCS-XI, NCT05820633).
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 08, 2026
Androgen deprivation therapy and kidney function in patients with prostate cancer: an analysis of the RADICAL-PC cohort.
Journal: International urology and nephrology
Published: December 09, 2025
Conventional vs. hypofractionated radiotherapy for high-risk prostate cancer (PCS5), randomized, non-inferiority, phase III trial: Post hoc analysis of radiation therapy toxicities and efficacy of IMRT compared to 3D-CRT.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 01, 2025
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP).
Journal: Future oncology (London, England)
Published: November 11, 2025
2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-resistant prostate cancer (Update).
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: August 06, 2025
Reply to 'Mitochondrial dysfunction as a crucial mediator of ADT-induced cardiovascular risk'.
Journal: Nature reviews. Urology
Published: June 05, 2025
2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-naive and castration-sensitive prostate cancer (Update).
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: May 21, 2025
Last Updated: 09/26/2026